Proactiveinvestors USA & Canada Hikma Pharmaceuticals PLC https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Hikma Pharmaceuticals PLC RSS feed en Tue, 01 Dec 2020 16:51:57 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Hikma Pharmaceuticals and Arecor strike a second strategic partnership deal https://www.proactiveinvestors.com/companies/news/931903/hikma-pharmaceuticals-and-arecor-strike-a-second-strategic-partnership-deal-931903.html Tue, 20 Oct 2020 11:50:00 -0400 https://www.proactiveinvestors.com/companies/news/931903/hikma-pharmaceuticals-and-arecor-strike-a-second-strategic-partnership-deal-931903.html Hikma Pharmaceuticals cuts 2020 guidance after delay in GSK knock-off approval https://www.proactiveinvestors.com/companies/news/929644/hikma-pharmaceuticals-cuts-2020-guidance-after-delay-in-gsk-knock-off-approval-929644.html Tue, 22 Sep 2020 07:24:00 -0400 https://www.proactiveinvestors.com/companies/news/929644/hikma-pharmaceuticals-cuts-2020-guidance-after-delay-in-gsk-knock-off-approval-929644.html Hikma hiked by Goldman Sachs on 'underappreciated' generic drugs arm https://www.proactiveinvestors.com/companies/news/928531/hikma-hiked-by-goldman-sachs-on--underappreciated--generic-drugs-arm-928531.html Tue, 08 Sep 2020 11:30:00 -0400 https://www.proactiveinvestors.com/companies/news/928531/hikma-hiked-by-goldman-sachs-on--underappreciated--generic-drugs-arm-928531.html Hikma Pharma climbs after US court's generic drug ruling https://www.proactiveinvestors.com/companies/news/928305/hikma-pharma-climbs-after-us-court-s-generic-drug-ruling-928305.html Fri, 04 Sep 2020 10:10:00 -0400 https://www.proactiveinvestors.com/companies/news/928305/hikma-pharma-climbs-after-us-court-s-generic-drug-ruling-928305.html Hikma Pharmaceuticals raises dividend as coronavirus drives injectables demand https://www.proactiveinvestors.com/companies/news/926100/hikma-pharmaceuticals-raises-dividend-as-coronavirus-drives-injectables-demand-926100.html Fri, 07 Aug 2020 07:17:00 -0400 https://www.proactiveinvestors.com/companies/news/926100/hikma-pharmaceuticals-raises-dividend-as-coronavirus-drives-injectables-demand-926100.html Hikma Pharma upgraded to ‘overweight’ from ‘equal-weight’ by Morgan Stanley in note highlighting “hidden operating leverage” https://www.proactiveinvestors.com/companies/news/923600/hikma-pharma-upgraded-to-overweight-from-equal-weight-by-morgan-stanley-in-note-highlighting-hidden-operating-leverage-923600.html Tue, 07 Jul 2020 09:51:00 -0400 https://www.proactiveinvestors.com/companies/news/923600/hikma-pharma-upgraded-to-overweight-from-equal-weight-by-morgan-stanley-in-note-highlighting-hidden-operating-leverage-923600.html Hikma Pharmaceuticals majority shareholder offloads entire stake https://www.proactiveinvestors.com/companies/news/922568/hikma-pharmaceuticals-majority-shareholder-offloads-entire-stake-922568.html Tue, 23 Jun 2020 13:09:00 -0400 https://www.proactiveinvestors.com/companies/news/922568/hikma-pharmaceuticals-majority-shareholder-offloads-entire-stake-922568.html Hikma Pharmaceuticals says generic Vascepa approved by US FDA https://www.proactiveinvestors.com/companies/news/920242/hikma-pharmaceuticals-says-generic-vascepa-approved-by-us-fda-920242.html Fri, 22 May 2020 08:08:00 -0400 https://www.proactiveinvestors.com/companies/news/920242/hikma-pharmaceuticals-says-generic-vascepa-approved-by-us-fda-920242.html Hikma sees pandemic-driven demand spike https://www.proactiveinvestors.com/companies/news/918482/hikma-sees-pandemic-driven-demand-spike-918482.html Thu, 30 Apr 2020 08:53:00 -0400 https://www.proactiveinvestors.com/companies/news/918482/hikma-sees-pandemic-driven-demand-spike-918482.html Hikma Pharmaceuticals upgraded to ‘overweight’ by JP Morgan after Vascepa litigation win https://www.proactiveinvestors.com/companies/news/916485/hikma-pharmaceuticals-upgraded-to-overweight-by-jp-morgan-after-vascepa-litigation-win-916485.html Thu, 02 Apr 2020 11:53:00 -0400 https://www.proactiveinvestors.com/companies/news/916485/hikma-pharmaceuticals-upgraded-to-overweight-by-jp-morgan-after-vascepa-litigation-win-916485.html Hikma wins litigation over heart disease prevention drug https://www.proactiveinvestors.com/companies/news/916199/hikma-wins-litigation-over-heart-disease-prevention-drug-916199.html Tue, 31 Mar 2020 07:34:00 -0400 https://www.proactiveinvestors.com/companies/news/916199/hikma-wins-litigation-over-heart-disease-prevention-drug-916199.html Hikma in nasal spray licence agreement, full-year profits soar https://www.proactiveinvestors.com/companies/news/913823/hikma-in-nasal-spray-licence-agreement-full-year-profits-soar-913823.html Thu, 27 Feb 2020 10:14:00 -0500 https://www.proactiveinvestors.com/companies/news/913823/hikma-in-nasal-spray-licence-agreement-full-year-profits-soar-913823.html Hikma hurt by JP Morgan downgrade to ‘underweight’ https://www.proactiveinvestors.com/companies/news/910022/hikma-hurt-by-jp-morgan-downgrade-to-underweight-910022.html Mon, 06 Jan 2020 10:10:00 -0500 https://www.proactiveinvestors.com/companies/news/910022/hikma-hurt-by-jp-morgan-downgrade-to-underweight-910022.html Hikma and Vectura make new application for GSK knock-off https://www.proactiveinvestors.com/companies/news/907965/hikma-and-vectura-make-new-application-for-gsk-knock-off-907965.html Wed, 27 Nov 2019 08:59:00 -0500 https://www.proactiveinvestors.com/companies/news/907965/hikma-and-vectura-make-new-application-for-gsk-knock-off-907965.html Hikma says “successfully” launching new products, reiterates guidance https://www.proactiveinvestors.com/companies/news/906504/hikma-says-successfully-launching-new-products-reiterates-guidance-906504.html Thu, 07 Nov 2019 09:30:00 -0500 https://www.proactiveinvestors.com/companies/news/906504/hikma-says-successfully-launching-new-products-reiterates-guidance-906504.html Hikma looking healthy as it upgrades full-year forecasts following strong first half https://www.proactiveinvestors.com/companies/news/900436/hikma-looking-healthy-as-it-upgrades-full-year-forecasts-following-strong-first-half-900436.html Fri, 09 Aug 2019 07:15:00 -0400 https://www.proactiveinvestors.com/companies/news/900436/hikma-looking-healthy-as-it-upgrades-full-year-forecasts-following-strong-first-half-900436.html Hikma Pharma repeats guidance as it ‘gets off to good start’ in 2019 https://www.proactiveinvestors.com/companies/news/220487/hikma-pharma-repeats-guidance-as-it-gets-off-to-good-start-in-2019-220487.html Fri, 17 May 2019 07:45:00 -0400 https://www.proactiveinvestors.com/companies/news/220487/hikma-pharma-repeats-guidance-as-it-gets-off-to-good-start-in-2019-220487.html Hikma Pharma gets boost from Citigroup upgrade to ‘buy’ from ‘hold’ on growth outlook for 2019 https://www.proactiveinvestors.com/companies/news/216749/hikma-pharma-gets-boost-from-citigroup-upgrade-to-buy-from-hold-on-growth-outlook-for-2019-216749.html Tue, 19 Mar 2019 11:16:00 -0400 https://www.proactiveinvestors.com/companies/news/216749/hikma-pharma-gets-boost-from-citigroup-upgrade-to-buy-from-hold-on-growth-outlook-for-2019-216749.html Hikma Pharma falls as it narrowly misses forecasts with 2018 results https://www.proactiveinvestors.com/companies/news/216368/hikma-pharma-falls-as-it-narrowly-misses-forecasts-with-2018-results-216368.html Wed, 13 Mar 2019 09:27:00 -0400 https://www.proactiveinvestors.com/companies/news/216368/hikma-pharma-falls-as-it-narrowly-misses-forecasts-with-2018-results-216368.html Hikma Pharmaceuticals secures anti-viral licensing deal https://www.proactiveinvestors.com/companies/news/211902/hikma-pharmaceuticals-secures-anti-viral-licensing-deal-211902.html Thu, 03 Jan 2019 09:21:00 -0500 https://www.proactiveinvestors.com/companies/news/211902/hikma-pharmaceuticals-secures-anti-viral-licensing-deal-211902.html Hikma Pharma gets shot in the arm from licensing and supply deal with China's Hansoh; Jefferies upgrade https://www.proactiveinvestors.com/companies/news/210035/hikma-pharma-gets-shot-in-the-arm-from-licensing-and-supply-deal-with-china-s-hansoh-jefferies-upgrade-210035.html Tue, 27 Nov 2018 12:23:00 -0500 https://www.proactiveinvestors.com/companies/news/210035/hikma-pharma-gets-shot-in-the-arm-from-licensing-and-supply-deal-with-china-s-hansoh-jefferies-upgrade-210035.html Hikma Pharma moved to ‘Hold’ from ‘Add’ by Peel Hunt on valuation grounds, says forecast upgrades already priced in https://www.proactiveinvestors.com/companies/news/209007/hikma-pharma-moved-to-hold-from-add-by-peel-hunt-on-valuation-grounds-says-forecast-upgrades-already-priced-in-209007.html Mon, 12 Nov 2018 10:13:00 -0500 https://www.proactiveinvestors.com/companies/news/209007/hikma-pharma-moved-to-hold-from-add-by-peel-hunt-on-valuation-grounds-says-forecast-upgrades-already-priced-in-209007.html Hikma and Vectura to develop generic version of GSK’s blockbuster Ellipta inhaler https://www.proactiveinvestors.com/companies/news/208820/hikma-and-vectura-to-develop-generic-version-of-gsks-blockbuster-ellipta-inhaler-208820.html Thu, 08 Nov 2018 09:25:00 -0500 https://www.proactiveinvestors.com/companies/news/208820/hikma-and-vectura-to-develop-generic-version-of-gsks-blockbuster-ellipta-inhaler-208820.html Hikma Pharma zips higher as it upgrades full-year guidance following strong first half https://www.proactiveinvestors.com/companies/news/202938/hikma-pharma-zips-higher-as-it-upgrades-full-year-guidance-following-strong-first-half-202938.html Wed, 15 Aug 2018 08:47:00 -0400 https://www.proactiveinvestors.com/companies/news/202938/hikma-pharma-zips-higher-as-it-upgrades-full-year-guidance-following-strong-first-half-202938.html Numis cuts Hikma Pharma to ‘hold’ from ‘add’ on valuation grounds ahead of upcoming interims https://www.proactiveinvestors.com/companies/news/202578/numis-cuts-hikma-pharma-to-hold-from-add-on-valuation-grounds-ahead-of-upcoming-interims-202578.html Thu, 09 Aug 2018 10:51:00 -0400 https://www.proactiveinvestors.com/companies/news/202578/numis-cuts-hikma-pharma-to-hold-from-add-on-valuation-grounds-ahead-of-upcoming-interims-202578.html Numis Securities trims rating for Hikma Pharmaceuticals to ‘add’ from ‘buy’ on valuation grounds after update https://www.proactiveinvestors.com/companies/news/197278/numis-securities-trims-rating-for-hikma-pharmaceuticals-to-add-from-buy-on-valuation-grounds-after-update-197278.html Fri, 18 May 2018 10:17:00 -0400 https://www.proactiveinvestors.com/companies/news/197278/numis-securities-trims-rating-for-hikma-pharmaceuticals-to-add-from-buy-on-valuation-grounds-after-update-197278.html Hikma Pharmaceuticals shares slip as guidance maintained though current year has got off to “an encouraging start” https://www.proactiveinvestors.com/companies/news/197260/hikma-pharmaceuticals-shares-slip-as-guidance-maintained-though-current-year-has-got-off-to-an-encouraging-start-197260.html Fri, 18 May 2018 08:05:00 -0400 https://www.proactiveinvestors.com/companies/news/197260/hikma-pharmaceuticals-shares-slip-as-guidance-maintained-though-current-year-has-got-off-to-an-encouraging-start-197260.html Drugs working for Hikma Pharma as shares propelled higher by rating upgrades from both Citigroup and Jefferies https://www.proactiveinvestors.com/companies/news/193232/drugs-working-for-hikma-pharma-as-shares-propelled-higher-by-rating-upgrades-from-both-citigroup-and-jefferies-193232.html Thu, 15 Mar 2018 11:53:00 -0400 https://www.proactiveinvestors.com/companies/news/193232/drugs-working-for-hikma-pharma-as-shares-propelled-higher-by-rating-upgrades-from-both-citigroup-and-jefferies-193232.html Hikma Pharmaceuticals posts loss after US write-down https://www.proactiveinvestors.com/companies/news/193141/hikma-pharmaceuticals-posts-loss-after-us-write-down-193141.html Wed, 14 Mar 2018 14:27:00 -0400 https://www.proactiveinvestors.com/companies/news/193141/hikma-pharmaceuticals-posts-loss-after-us-write-down-193141.html Hikma Pharmaceuticals and Vectura hit by US regulatory setback https://www.proactiveinvestors.com/companies/news/192974/hikma-pharmaceuticals-and-vectura-hit-by-us-regulatory-setback-192974.html Mon, 12 Mar 2018 08:02:00 -0400 https://www.proactiveinvestors.com/companies/news/192974/hikma-pharmaceuticals-and-vectura-hit-by-us-regulatory-setback-192974.html